What sector does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) operate in?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) current stock price?
As of the latest data, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd stock price is HK$2.85, with a previous close of HK$2.78. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd gained HK$0.07 in the last trading session, representing a 2.52% increase.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) current market capitalization?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd market cap is approximately 969.00 million.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) Earnings Per Share (EPS)?
The trailing EPS is -HK$0.07.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) EBITDA?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -137.30 million.
Does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) pay dividends?
Yes. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd pays annual dividends with an annualized yield of 1.13% and an estimated annual payout of HK$0.03 per share.
When is the next ex-dividend date for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349)?
The next ex-dividend date is scheduled for July 10, 2026.
When is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) next earnings report?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is expected to release its next earnings report on December 31, 2025.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) beta (volatility) score?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd has a beta of 0.122, indicating lower volatility than the overall market.
